id RCAP_7a7b6a292bed5880f2c0cd30fb874ba0
oai_identifier_str oai:run.unl.pt:10362/170016
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018Is It a Changing Landscape?classical PKUhyperphenylalaninaemiametabolic controlmild PKUmonitoringphenylalaninephenylketonuriasapropterintyrosineFood ScienceNutrition and DieteticsPublisher Copyright: © 2024 by the authors.Background: In 2011, a European phenylketonuria (PKU) survey reported that the blood phenylalanine (Phe) levels were well controlled in early life but deteriorated with age. Other studies have shown similar results across the globe. Different target blood Phe levels have been used throughout the years, and, in 2017, the European PKU guidelines defined new targets for blood Phe levels. This study aimed to evaluate blood Phe control in patients with PKU across Europe. Methods: nine centres managing PKU in Europe and Turkey participated. Data were collected retrospectively from medical and dietetic records between 2012 and 2018 on blood Phe levels, PKU severity, and medications. Results: A total of 1323 patients (age range:1–57, 51% male) participated. Patient numbers ranged from 59 to 320 in each centre. The most common phenotype was classical PKU (n = 625, 48%), followed by mild PKU (n = 357, 27%) and hyperphenylalaninemia (HPA) (n = 325, 25%). The mean percentage of blood Phe levels within the target range ranged from 65 ± 54% to 88 ± 49% for all centres. The percentage of Phe levels within the target range declined with increasing age (<2 years: 89%; 2–5 years: 84%; 6–12 years: 73%; 13–18 years: 85%; 19–30 years: 64%; 31–40 years: 59%; and ≥41 years: 40%). The mean blood Phe levels were significantly lower and the percentage within the target range was significantly higher (p < 0.001) in patients with HPA (290 ± 325 μmol/L; 96 ± 24%) and mild PKU (365 ± 224 μmol/L; 77 ± 36%) compared to classical PKU (458 ± 350 μmol/L, 54 ± 46%). There was no difference between males and females in the mean blood Phe levels (p = 0.939), but the percentage of Phe levels within the target range was higher in females among school-age children (6–12 years; 83% in females vs. 78% in males; p = 0.005), adolescents (13–18 years; 62% in females vs. 59% in males; p = 0.034) and adults (31–40 years; 65% in females vs. 41% in males; p < 0.001 and >41 years; 43% in females vs. 28% in males; p < 0.001). Patients treated with sapropterin (n = 222) had statistically significantly lower Phe levels compared to diet-only-treated patients (mean 391 ± 334 μmol/L; percentage within target 84 ± 39% vs. 406 ± 334 μmol/L; 73 ± 41%; p < 0.001), although a blood Phe mean difference of 15 µmol/L may not be clinically relevant. An increased frequency of blood Phe monitoring was associated with better metabolic control (p < 0.05). The mean blood Phe (% Phe levels within target) from blood Phe samples collected weekly was 271 ± 204 μmol/L, (81 ± 33%); for once every 2 weeks, it was 376 ± 262 μmol/L, (78 ± 42%); for once every 4 weeks, it was 426 ± 282 μmol/L, (71 ± 50%); and less than monthly samples, it was 534 ± 468 μmol/L, (70 ± 58%). Conclusions: Overall, blood Phe control deteriorated with age. A higher frequency of blood sampling was associated with better blood Phe control with less variability. The severity of PKU and the available treatments and resources may impact the blood Phe control achieved by each treatment centre.NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)Centro de Investigação em Tecnologias e Serviços de Saúde (CINTESIS)Comprehensive Health Research Centre (CHRC) - pólo NMSRUNPinto, AlexAhring, KirstenAlmeida, Manuela FerreiraAshmore, CatherineBélanger-Quintana, AmayaBurlina, AlbertoCoşkun, TurgayDaly, Annevan Dam, EstherDursun, AliEvans, SharonFeillet, FrançoisGiżewska, MariaGökmen-Özel, HulyaHickson, MaryHoekstra, YtekeIlgaz, FatmaJackson, RichardLeśniak, AlicjaLoro, ChristianMalicka, KatarzynaPatalan, MichałRocha, Júlio CésarSivri, SerapRodenburg, Irisvan Spronsen, FrancjanStrączek, KamillaTokatli, AyşegülMacDonald, Anita2024-07-25T22:21:25Z2024-072024-07-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10362/170016eng1422-8599PURE: 95549901https://doi.org/10.3390/nu16132064info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2024-09-09T01:39:08Zoai:run.unl.pt:10362/170016Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T18:46:57.952215Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018
Is It a Changing Landscape?
title Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018
spellingShingle Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018
Pinto, Alex
classical PKU
hyperphenylalaninaemia
metabolic control
mild PKU
monitoring
phenylalanine
phenylketonuria
sapropterin
tyrosine
Food Science
Nutrition and Dietetics
title_short Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018
title_full Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018
title_fullStr Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018
title_full_unstemmed Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018
title_sort Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018
author Pinto, Alex
author_facet Pinto, Alex
Ahring, Kirsten
Almeida, Manuela Ferreira
Ashmore, Catherine
Bélanger-Quintana, Amaya
Burlina, Alberto
Coşkun, Turgay
Daly, Anne
van Dam, Esther
Dursun, Ali
Evans, Sharon
Feillet, François
Giżewska, Maria
Gökmen-Özel, Hulya
Hickson, Mary
Hoekstra, Yteke
Ilgaz, Fatma
Jackson, Richard
Leśniak, Alicja
Loro, Christian
Malicka, Katarzyna
Patalan, Michał
Rocha, Júlio César
Sivri, Serap
Rodenburg, Iris
van Spronsen, Francjan
Strączek, Kamilla
Tokatli, Ayşegül
MacDonald, Anita
author_role author
author2 Ahring, Kirsten
Almeida, Manuela Ferreira
Ashmore, Catherine
Bélanger-Quintana, Amaya
Burlina, Alberto
Coşkun, Turgay
Daly, Anne
van Dam, Esther
Dursun, Ali
Evans, Sharon
Feillet, François
Giżewska, Maria
Gökmen-Özel, Hulya
Hickson, Mary
Hoekstra, Yteke
Ilgaz, Fatma
Jackson, Richard
Leśniak, Alicja
Loro, Christian
Malicka, Katarzyna
Patalan, Michał
Rocha, Júlio César
Sivri, Serap
Rodenburg, Iris
van Spronsen, Francjan
Strączek, Kamilla
Tokatli, Ayşegül
MacDonald, Anita
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
Centro de Investigação em Tecnologias e Serviços de Saúde (CINTESIS)
Comprehensive Health Research Centre (CHRC) - pólo NMS
RUN
dc.contributor.author.fl_str_mv Pinto, Alex
Ahring, Kirsten
Almeida, Manuela Ferreira
Ashmore, Catherine
Bélanger-Quintana, Amaya
Burlina, Alberto
Coşkun, Turgay
Daly, Anne
van Dam, Esther
Dursun, Ali
Evans, Sharon
Feillet, François
Giżewska, Maria
Gökmen-Özel, Hulya
Hickson, Mary
Hoekstra, Yteke
Ilgaz, Fatma
Jackson, Richard
Leśniak, Alicja
Loro, Christian
Malicka, Katarzyna
Patalan, Michał
Rocha, Júlio César
Sivri, Serap
Rodenburg, Iris
van Spronsen, Francjan
Strączek, Kamilla
Tokatli, Ayşegül
MacDonald, Anita
dc.subject.por.fl_str_mv classical PKU
hyperphenylalaninaemia
metabolic control
mild PKU
monitoring
phenylalanine
phenylketonuria
sapropterin
tyrosine
Food Science
Nutrition and Dietetics
topic classical PKU
hyperphenylalaninaemia
metabolic control
mild PKU
monitoring
phenylalanine
phenylketonuria
sapropterin
tyrosine
Food Science
Nutrition and Dietetics
description Publisher Copyright: © 2024 by the authors.
publishDate 2024
dc.date.none.fl_str_mv 2024-07-25T22:21:25Z
2024-07
2024-07-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/170016
url http://hdl.handle.net/10362/170016
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1422-8599
PURE: 95549901
https://doi.org/10.3390/nu16132064
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833597661261856768